Berkshire Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Sell
1,082
-73
-6% -$40.9K 0.11% 104
2026
Q1
$649K Sell
1,155
-100
-8% -$64.1K 0.13% 94
2025
Q4
$849K Sell
1,255
-239
-16% -$163K 0.17% 78
2025
Q3
$955K Sell
1,494
-70
-4% -$42.5K 0.21% 74
2025
Q2
$839K Buy
1,564
+7
+0.4% +$3.35K 0.19% 75
2025
Q1
$654K Buy
1,557
+4
+0.3% +$1.74K 0.16% 86
2024
Q4
$642K Buy
1,553
+80
+5% +$35.1K 0.15% 87
2024
Q3
$744K Buy
1,473
+115
+8% +$55.9K 0.17% 82
2024
Q2
$662K Sell
1,358
-22
-2% -$11K 0.17% 81
2024
Q1
$745K Buy
1,380
+20
+1% +$10.9K 0.19% 84
2023
Q4
$755K Buy
1,360
+2
+0.1% +$939 0.2% 81
2023
Q3
$594K Sell
1,358
-21
-2% -$10.5K 0.17% 84
2023
Q2
$693K Sell
1,379
-5
-0.4% -$2.4K 0.19% 80
2023
Q1
$692K Sell
1,384
-30
-2% -$14.4K 0.21% 79
2022
Q4
$577K Sell
1,414
-195
-12% -$75.7K 0.18% 86
2022
Q3
$524K Buy
1,609
+31
+2% +$11.4K 0.16% 86
2022
Q2
$553K Buy
1,578
+18
+1% +$7.34K 0.16% 84
2022
Q1
$854K Buy
1,560
+79
+5% +$41.6K 0.2% 76
2021
Q4
$975K Buy
1,481
+34
+2% +$21.3K 0.22% 75
2021
Q3
$900K Sell
1,447
-25
-2% -$16.8K 0.22% 79
2021
Q2
$930K Buy
1,472
+36
+3% +$19.9K 0.22% 78
2021
Q1
$702K Buy
1,436
+1
+0.1% +$501 0.18% 82
2020
Q4
$717K Buy
1,435
+317
+28% +$142K 0.18% 78
2020
Q3
$440K Buy
+1,118
New +$413K 0.12% 97

Other funds holding IDXX

Berkshire Bank's IDXX Position: Q2 2026 in Review

Berkshire Bank reduced its Idexx Laboratories (IDXX) stake by 6.3% in Q2 2026, selling an estimated $40.9K and leaving 1,082 shares worth $570K. The position accounts for 0.11% of the portfolio, ranked #104.

Berkshire Bank first reported a position in IDXX in Q3 2020 and has held it in 24 quarters since. The position peaked at $975K in Q4 2021. 545 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Berkshire Bank held 1,082 shares of Idexx Laboratories worth $570K as of Q2 2026.
  • Berkshire Bank sold 73 Idexx Laboratories shares in Q2 2026, an estimated $40.9K.
  • Idexx Laboratories made up 0.11% of Berkshire Bank's portfolio in Q2 2026, its #104 holding.
  • Berkshire Bank first reported a position in Idexx Laboratories in Q3 2020 and has held it in 24 quarters since.
  • Berkshire Bank's Idexx Laboratories position peaked at $975K in Q4 2021.
  • 545 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.